Latest Breaking News On - Seyltx inc - Page 2 : comparemela.com

Algernon Pharmaceuticals Announces Closing of the Acquisition of its Chronic Cough Research Program by U S Based Seyltx for USD $2M and a 20% Equity Position

Algernon Pharmaceuticals Announces Closing of the Acquisition of its Chronic Cough Research Program by U S Based Seyltx for USD $2M and a 20% Equity Position
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesBritish columbiaUnited kingdomDietricha stephanChristopherj moreauAlgernon ifenprodilMaxim groupCanadian securities exchangeNeither the canadian securities exchangeAlgernon pharmaceuticals announces closing of the acquisitionMerck coAlgernon pharmaceuticalsDrug administrationNo securities exchangeBellus healthAfferent pharmaceuticals

Algernon Pharmaceuticals closes $2M acquisition of its chronic cough research program by Seyltx

Algernon Pharmaceuticals closes $2M acquisition of its chronic cough research program by Seyltx
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Christopher moreauDietrich stephanMarket researchSeyltx incDrug administrationAlgernon pharmaceuticals incAlgernon pharmaceuticalsBridge market research

Algernon Pharmaceuticals Announces LOI for the Acquisition of its Chronic Cough Research Program by U S Based Seyltx for USD $2M and a 20% Equity Position

Algernon Pharmaceuticals Announces LOI for the Acquisition of its Chronic Cough Research Program by U S Based Seyltx for USD $2M and a 20% Equity Position
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

British columbiaUnited statesRheinland pfalzUnited kingdomChristopherj moreauNo securities exchangeMerck coAlgernon pharmaceuticals incCompany or algernonDrug administrationMarket researchAlgernon pharmaceuticalsCanadian securities exchangeBellus healthNeither the canadian securities exchangeAfferent pharmaceuticals